January 2025

SAN FRANCISCO and SUZHOU, China, Jan. 2, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metaboli

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: